chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2022 at 12:31 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 28-Jan-2022 at 12:31 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported that patient ethnicity reported as private. The patient received Moderna vaccine on 28-Jan-2022 12:31:30, past its 30 day of expiry date. Vaccine went into 2 to 8 degree Celsius thaw state on or about 24-Dec-2021. This vaccine was administered up until its manufacturing expiry date of 04-Apr-2022.  No treatment medications were provided.   This case was linked to MOD-2022-542869 (Patient Link).
Moderna COVID-19 Vaccine EUA Moderate warmth and tingling to lips and tongue. Moderate dry mouth. Rapid heartbeat. Very mild chest tightness. Mild dizziness/foggyness.
damage to her right eye and loss of vision; damage to her right eye and loss of vision; Information has been received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Information about concurrent condition, concomitant medication and medical history was not provided. On an unknown date, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, lot # and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). After receiving zoster vaccine live (ZOSTAVAX) vaccine, the patient suffered damage to her right eye and loss of vision. As a result of these symptoms, she was seen and treated by medical providers and was still under their care. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms had resulted in physical limitations not present prior to vaccination. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of manufacturer, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. She also had incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was considered as not recovered. The causality between the events and zoster vaccine live (ZOSTAVAX) was related.   Upon internal review, loss of vision was determined to be medically significant. The events of damage to her right eye and loss of vision were assessed as disabled.
This case was reported by a nurse and described the occurrence of expired vaccine used in a patient who received FLUARIX. On an unknown date, the patient received FLUARIX QIV at an unknown dose. On an unknown date, an unknown time after receiving FLUARIX, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional information: 30 expired doses of FLUARIX QIV were shipped from VFC and 14 doses were administered to patients. Nurse does not have any patient level information.
Upper right arm at injection site became sore.  This progressed down the arm an into the shoulder until there was little range of motion. By morning the pain was such that any activity with the arm caused light-headedness and ringing in the ears.  Treament was Tylenol and ice pack.  This slowly subsided over the course of two days.
My arm has been hurting for over a month. It is hard for me to pick things up without having to use both hands. My arm hurts its tender and   I  have a burning sensation. I also feels like my vein is being stretched.
My Grandson gave me RSV, before I was taking prednisone and tested positive 9 days earlier, I figured I had my immune system was wiped out because my immune defense was compromised. My medical biomedical son and friend who have worked at Pfizer have confirmed this. I contracted COVID-19, I had a mild sore throat that I thought was a cold. Then next day I was feeling worse. I had kind of a sinus headache and congestion. I tested at home and was positive for COVID-19. I went to my doctors immediately. I was for kidney function and since it was fine, they gave me PAXLOVID. I didn't like the taste, but it was bad. The headache never really went away. I tested after I finished my PAXLOVID, I was still positive. It looked like I was more positive than when I first tested. I felt fine by March 4th, 2023. For the first time in my life a week after I tested positive, I had an orgasm headache. I had two brain scans and an EKG. They figured it was not something in my brain, but perhaps my heart. I am scheduled to see a cardiologist.
Severe migraine that caused facial swelling / tooth pain, high fever, chills, nausea / vomiting, sensitivity to light, severe body aches and shooting neck and arm pain in injection site, shortness of breath, inability to hold down fluids or food. On second day, still severe fatigue / having trouble standing and sweats / chills / migraine / nausea. Upper jaw Tooth pain is gone on right side. Symptoms started on right side of body and then spread out. Injection site swelling and pain. Nearly went to the ER, will follow up with my doctor when I can get to the doctor, managing with tons of Advil.
Hives developed around mouth and face - symptoms started approximately 1 hour after dose administration; Denies SOB. Wanted a benadryl 25mg given at 2004. Discharged at 2007.
Within one hour of my booster shot my left foot, namely the heal, began to hurt. It was so bad I could barely walk. I am still in a lot of pain  3 weeks later. I also felt so ill that I thought I may need to go to the hospital. I was shivering, feeling hot, headache, muscle aches, joint pain,  I felt horrible all over my body. I called a nurse practitioner friend of mine for advice, and decided to stay home. I was sick for several days. My foot on some days is very gradually getting better, on other days it still hurts to the point that I limp and am in great pain.
Tiredness; Headache; Fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "Tiredness"; HEADACHE (non-serious), outcome "unknown", described as "Headache"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021504805 same reporter/drug/AE, different patient;US-PFIZER INC-2021487558 same reporter/drug/AE, different patient
Patient is experiencing uncontrollable pruritis in entire body.  The itching is accompanied with a small fine rash. He is experiencing insomnia.  Patient has been treating with benadryl around the clock and has not had any relief. Recommended patient follow up with physician.
On 5/19/2021: Fever of unknown temp beginning at 8pm. Fever caused inability to sleep. Fever broke around 4am. Extreme fatigue and muscle aches that caused inability to work. Began at about noon and continued through midnight. On 5/20/2021: Severe bone/joint pain in the shoulders that caused inability to sleep beginning about 9pm. Pain unmitigated by 800mg ibuprofen and topical analgesic. Minimal relief from icing the area. Pain not in the muscle. Extreme tenderness when pushing on shoulder blades. Minimal tenderness to muscle around shoulder blade. Pain subsided around 4am. Soreness and minimal pain on morning of 5/21/2021.
Patient states two hours post vaccination, she had chest pain, describes "pushing or sitting on my chest" for approximately 30 to 40 minutes subsiding slowly. Then, fell "instantly asleep" for two hours. States abnormal for her. PCP notified.
doesn't feel good; migraine level headaches; body aches; injection site pain; Tiredness; headache; muscle pain; Chills; Nausea; arm is still a little sore; bottom of the arm hurt; she couldn't move it; This is a spontaneous report from a contactable other healthcare professional (patient). A 46-year-old female patient received first dose of bnt162b2 (Pfizer Biontech COVID 19 vaccine), Lot number: EH9899, intramuscular in the deltoid on 17Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  She works in Urgent Care and has to swab people with COVID all day long. The caller had the injection on 17Dec2020 and still doesn't feel good. The patient is a medical assistant calling because of herself. She did not want to go back to work, she does not feel good, she has a headache that is horrible, migraine level headache and a few body aches. This happened two hours after the injection- she had injection site pain, tiredness, headache, muscle pain, chills, nausea. She also stated that her arm is still a little sore, she got it in the deltoid, and the bottom of the arm hurt, she couldn't move it, but the next day, her arm was fine. The outcome of body aches, tiredness, muscle pain, chills, nausea was recovering; migraine level headaches and headaches was not recovered; doesn't feel good and injection site pain was unknown; arm is still a little sore; bottom of the arm hurt and she couldn't move it recovered on an unspecified date.
Developed a rash near the injection site again / raised but it does not itch; This case was reported by a consumer and described the occurrence of raised rash in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of rash papular (received 1st dose in November 2020, refer case US2021070489).   On 8th March 2021, the patient received the 2nd dose of Shingrix. In March 2021, less than 3 weeks after receiving Shingrix, the patient experienced raised rash. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the raised rash was not recovered/not resolved.   It was unknown if the reporter considered the raised rash to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient herself. The patient received Shingrix and developed a rash near the injection site. The reporter describes the rash as raised but it did not itch.  The patient would see a dermatologist soon.  No other information given by the patient. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021070489:Same reporter.
8 y/o presented for COVID-19 vaccine. Adult formulation of Pfizer Covid-19 vaccine diluted in error with 1.3 cc of diluent and 0.2 cc administered to 8 y/o via IM injection in left deltoid. Error realized soon after child left clinic. Parent notified. Instructed to monitor for adverse events. 12/18/2021-F/U by phone, no problems reported.
Information has been received from a physician referring to a 3 year old patient. The patients' pertinent medical histories and concomitant therapies were not reported. On 26-AUG-2016, the patient received a dose of improperly stored VAQTA (lot # M017982, expiration date: 13-SEP-2017)(dose and route of administration were not provided). No adverse symptoms were reported. No product quality complaint (PQC) was involved. This is one of 5 reports received form the same reporter. Additional information has been requested.
Information has been received from a health professional concerning a 4 year old male with asthma, reflux and unknown seasonal allergies, who on 12-APR-2006 was vaccinated with a dose of MMR II (Lot# 649807/0487R). Concomitant therapy included a dose of Dtp and a dose of poliovirus vaccine. It was reported that the patient developed vomiting, fever and a rash over his whole body after vaccination. The patient was taken to the emergency room and treated with intravenous fluids, TYLENOL, and another unspecified medication. The patient was hospitalized in the emergency room overnight. It was reported that the patient recovered. The reporter felt that the patient's reactions were other important medical events. Additional information has been requested.
Sore/painful neck; Sore/painful neck from enlarged neck lymph nodes on same side of body as vaccine was given.; Sore/painful neck from enlarged neck lymph nodes on same side of body as vaccine was given.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An adult female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 12Mar2021 (Batch/Lot number: unknown) as dose number unknown for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NECK PAIN (non-serious) with onset 12Mar2021, outcome "not recovered", described as "Sore/painful neck"; LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious) all with onset 12Mar2021, outcome "not recovered" and all described as "Sore/painful neck from enlarged neck lymph nodes on same side of body as vaccine was given.". It was unknown if therapeutic measures were taken as a result of neck pain, lymphadenopathy, lymph node pain.  No follow-up attempts are possible. Information about lot/batch number cannot be requested. No further information is expected.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Idiopathic CD4 lymphocytopenia" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for Covid-19 Immunization; Covid-19 vaccine (DOSE 2, MANUFACTURER UNKNOWN), for Covid-19 Immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient given Paxlovid as treatment on 21Sep2023 to 26Sep2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnancy after 1st dose of Moderna COVID 19 vaccine) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. No Medical History information was reported. On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 11-Mar-2021 and the estimated date of delivery was 16-Dec-2021. On 03-May-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnancy after 1st dose of Moderna COVID 19 vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourth week of the pregnancy. On 03-May-2021, EXPOSURE DURING PREGNANCY (Pregnancy after 1st dose of Moderna COVID 19 vaccine) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-May-2021, Pregnancy test: positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication details were reported. No treatment medication details was reported.
Pt received vaccines-went to check out area and passed out. Examined by provided-did not hit head, vasovagal response. Did not eat breakfast today.
I Just have couple reactions; hands are locking up; Weird finger development; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 66-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6198), via an unspecified route of administration on an unspecified date (at the age of 66-year-old) as dose 1, single for covid-19 immunisation.  The patient medical history was not reported. There were no concomitant medications. Patient experienced BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: not reported), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. On an unspecified date, the patient experienced i just have couple reactions; hands are locking up, weird finger development. Patient had three problem areas, three fingers that were acting bizarre on my right hand and my thumb on my left hand. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
18 hours of chills, then 7 days of inflamed arm, after receiving pneumococcal polysaccharide vaccine, spreading to over 6 inches in circumference at sight of injection.  Arm reddened, hot and itchy increasing and peaking on 4th day and then gradually subsiding, finally normalizing by 7 or 8th day.
Patient came in on 6/28/21 for an appointment and was offered her second Shingrix vaccine.  She states that she had angioedema and declined vaccine two.  On the day of the first vaccination she received TDAP and also started Prednisone at the same time.
Information has been received from a physician concerning a 23 year old female who on 19-FEB-2008 was vaccinated in the right deltoid with the first dose of GARDASIL (659655/1486U). Concomitant therapy included ADACEL. On 19-FEB-2008 the patient experienced fever, nausea, vomiting and profound fatigue. Treatment included increased fluids and BRAT diet as tolerated. TYLENOL was prescribed for fever as needed. As of 21-FEB-2008, the patient was recovering. Subsequently, the patient recovered on 22-Feb-2008. Additional information has been requested. No further information is expected.
Patient reporting numbness and decreased grip strength in her hands. She came to pharmacy initially to get non-safety caps to help her get her tops of the medication better as she was having difficulty. She said it started after receiving the vaccine. It has improved since date of intial start and is slowly getting better.
Moderna COVID-19 Vaccine EUA: Vaccine recipient further reported to have a history of sarcoidosis (2010), valve replacement (2014), and dual pacemaker/defibrillator (July 2021). She has had sarcoidosis since 2010 and never had any symptoms. She reported in July 2021, she had a bout of ventricular tachycardia and subsequently had a pacemaker/defibrillator implanted. A scan revealed myocarditis. She was subsequently diagnosed with inflammation of the heart secondary to sarcoidosis. She had concerns that the Moderna vaccine may have exacerbated her heart condition.
Tachycardia, high blood pressure, flushing Given Benadryl and observed in the ER
On 01/28/2021, the day of my vaccination I had smooth skin on my upper arm. By the late part of April I noticed a bump going on under my skin, and my first thought I remember that's where I had my injection. On 04/28/20 went to my dermatologist, and it was biopsied. The biopsy results: squamous cell carcinoma. On 06/14/2021, they removed the growth, about the size of quarter and deep to make sure they removed any cancer that was there.
Received a steroid shot the same day. Later that night she had serious diarrhea and her eyes started blinking uncontrollable. Blood pressure shot up to 185/101. Been to the ER 3xs and urgent care twice. She was put on prednisone which made her have trouble breathing .
chills, fever between 99.5-100.5, arthralgias, felt unwell; also general malaise; took APAP; 15NOV93 phone in pt called again cont to have sx; encouraged again to seek med advice; 16NOV93 pt stated MD dx walking pneumonia;
Pregnancy History: G2P1011 (now), 1 term birth on 5/14/2019 without complications.  Was pregnant at the time of vaccination with EDD 12/18/21 (so 2wks, 3 days pregnant by LMP), had a headache and sore arm the night of vaccination, then the following day started having mild abdominal pain and spotting at 1:30pm, then worsening bleeding at the level of a heavy period. Bleeding is still ongoing.
This 73    year old   black female received the Covid shot on 2/27/21   and went to the ED on  4/29/21   and was admitted  on   4/29/21     with respiratory distress, cardiac arrest and other symptoms and died on  5/1/21 .  Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.
It was a rash that started small and grew to about two /two and a half inches in diameter over the course of the day.  My arm was very hot, warm to the touch and noticably swollen. I went to UC and received an antibiotic and a topical cream. The visable rash faded after about two days.
This subject is a 70 year old male who was admitted to the hospital due to right lung pneumonia while enrolled in the RSV11 study. The subject received his second injection of RSV vaccine or Placebo and Influenza vaccine on 10/29/03. Subject developed a temperature, shortness of breath, cough, wheeze, and cold symptoms 37 days post immunization and was admitted to the hospital on 12/5/03. Wife notified investigator that subject was taken to local MD on 5/12/03 with SOB, cold, cough, sputum and fever and was diagnosed with pneumonia by CXR. Treatment included Ibuprofen, Tylenol, Rocephin injection, Avalox and Tussionex. The temperature, SOB, coughing, wheezing, cold symptoms and diagnosis of right lung pneumonia was reported by the investigator as life threatening and possibly related to the study vaccine. Additional info received 12/15/03. The seriousness classification has been downgraded. The pneumonia as reported by the investigator did not meet the criteria for an SAE and should not have been reported.
Hives, pruritus, heartburn. Prednisone 60mg, Benadryl, med w/ 1 dose pack, Zyrtec, Rahitidine.